FRAZIER MANAGEMENT LLC
Filing Date
Global Rank
#1,504
/ 6,772
▼ 55
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
-2.4%
Period ended 4 years ago
Filed Feb 8, 2022 · 4y
8 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+65.9%
SPY
+76.3%
Annualised alpha
-2.4%
Max drawdown
−39.7%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
23 positions · as of Dec 31, 2021 · Δ vs Sep 30, 2021Top Position
20.3%
−3.3 pts
Top 5
53.7%
−14.7 pts
Top 10
76.1%
−9.1 pts
HHI
887
Diversified−416
Portfolio Trend
8 quarters · across all stocks
Sector Breakdown
As of Dec 31, 2021| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $859,715,708 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
6 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | +1,583,927 | 2,772,062 | $60,680,437 | |
| KALV | KalVista Pharmaceuticals, Inc. | +1,148,280 | 1,305,087 | $17,266,301 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | +532,987 | 1,384,293 | $39,327,764 | |
| AUTL | Autolus Therapeutics plc | +216,200 | 3,746,857 | $19,446,187 | |
| REPL | Replimune Group, Inc. | +158,864 | 650,862 | $17,638,360 | |
| BCYC | Bicycle Therapeutics PLC | +112,360 | 555,240 | $33,797,458 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IOVA | Iovance Biotherapeutics, Inc. | −926,677 | 1,747,622 | $33,362,103 | |
| No positions match the current search. | |||||
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
23 positions ·
$859,715,708 total
· as of Dec 31, 2021
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Held | 8,434,232 | $174,925,971 | 20.35% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
Held | 5,827,415 | $114,625,253 | 13.33% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Added | 2,772,062 | $60,680,437 | 7.06% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Held | 3,566,912 | $56,892,246 | 6.62% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Held | 2,309,554 | $54,944,289 | 6.39% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Held | 771,250 | $53,948,937 | 6.28% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Added | 1,384,293 | $39,327,764 | 4.57% | |
| BCYC |
Bicycle Therapeutics PLC
Healthcare
|
Added | 555,240 | $33,797,458 | 3.93% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
Reduced | 1,747,622 | $33,362,103 | 3.88% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Held | 1,417,157 | $31,886,032 | 3.71% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
Held | 899,700 | $31,264,575 | 3.64% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Held | 1,505,200 | $29,757,804 | 3.46% | |
| SLN |
Silence Therapeutics plc
Healthcare
|
NEW | 886,173 | $21,170,672 | 2.46% | |
| AUTL |
Autolus Therapeutics plc
Healthcare
|
Added | 3,746,857 | $19,446,187 | 2.26% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
Added | 650,862 | $17,638,360 | 2.05% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Held | 1,250,000 | $17,587,500 | 2.05% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Added | 1,305,087 | $17,266,301 | 2.01% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
NEW | 1,774,891 | $15,228,564 | 1.77% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
NEW | 163,763 | $13,451,492 | 1.56% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
Held | 235,809 | $7,710,954 | 0.90% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Held | 408,329 | $5,937,103 | 0.69% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Held | 585,759 | $4,990,666 | 0.58% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Held | 156,000 | $3,875,040 | 0.45% |